ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1960

Exome Sequencing Reveals Rare Recessive Mutations in Multiple Genes Including FAS, RAD51B, and ISG15 in a Single Family with Lupus and Suggests a Unique Genetic Model

Jessie Alperin1, Khader Mustafa2, Ola Hijjawi2, Patrick Coit3, Kenneth Kaufman4 and Amr H Sawalha3, 1University of Michigan Medical System, Ann Arbor, MI, 2Division of Rheumatology, The University of Jordan, Amman, Jordan, 3Division of Rheumatology, University of Michigan, Ann Arbor, MI, 4Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: family studies and genetics, Lupus

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Genetics, Genomics and Proteomics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Lupus is a complex heterogeneous disease, which can affect almost any organ system. The genetic etiology of lupus is complex, with multiple genetic susceptibility loci identified. Monogenic lupus, caused by a specific single gene defect, is less common but is generally characterized by early disease onset and more severe presentation. The aim of this study was to understand the genetic basis of a consanguineous family with multiple lupus affected siblings in order to gain insights into lupus pathogenesis.

Methods: DNA samples extracted from whole blood were obtained from all members of a family of 13 (11 siblings and their parents) with 3 sisters affected by early-onset lupus with renal and central nervous system complications. Whole exome sequencing was performed for the 3 affected sisters and both parents. Because of strong consanguinity between both parents (first degree cousins both from their paternal and maternal descents), we assumed a recessive genetic model and focused on identifying rare recessive variants in the affected sisters that are present in heterozygous forms in both parents. Variants were filtered for potentially protein damaging effects using SIFT, Polyphen2, MutationTaster, Mutation Assessor, and FATHMM functional prediction algorithms. Sanger sequencing and Sequenom genotyping were used for validation and genotyping all unaffected siblings.

Results: Using whole exome sequencing, we found that each sister has multiple rare recessive mutations, including rare predicted damaging coding mutations in genes such as FAS, RAD51B, and ISG15, involved in apoptosis, DNA damage repair, and interferonopathy, respectively. These recessive genotypes are exceedingly rare in the general population with expected frequencies of ~1, 9, and 3 in 100,000 individuals, respectively. Interestingly, these mutations were mutually exclusive in the affected sisters. While the ISG15 recessive mutation was not present in any unaffected sibling, homozygosity for the FAS and RAD51B mutations were not sufficient to explain lupus in the two other affected sisters as some of the unaffected siblings also have these recessive genotypes. Multiple other rare recessive variants enriched in genes related to apoptosis, inflammasome activation, and cell cycle regulation were identified in the affected sisters, suggesting that accumulation of multiple rare recessive variants underlies lupus phenotype in this family. Indeed, calculating genetic risk score using the total of 69 rare recessive variants identified in the affected sisters revealed a significantly higher genetic risk (~2 times) in the affected compared to unaffected siblings.

Conclusion: We describe a unique genetic model in a consanguineous family with lupus whereby the additive effect of a number of rare recessive variants in inflammatory pathways likely contributes to the disease phenotype within the same family.


Disclosure: J. Alperin, None; K. Mustafa, None; O. Hijjawi, None; P. Coit, None; K. Kaufman, None; A. H. Sawalha, None.

To cite this abstract in AMA style:

Alperin J, Mustafa K, Hijjawi O, Coit P, Kaufman K, Sawalha AH. Exome Sequencing Reveals Rare Recessive Mutations in Multiple Genes Including FAS, RAD51B, and ISG15 in a Single Family with Lupus and Suggests a Unique Genetic Model [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/exome-sequencing-reveals-rare-recessive-mutations-in-multiple-genes-including-fas-rad51b-and-isg15-in-a-single-family-with-lupus-and-suggests-a-unique-genetic-model/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exome-sequencing-reveals-rare-recessive-mutations-in-multiple-genes-including-fas-rad51b-and-isg15-in-a-single-family-with-lupus-and-suggests-a-unique-genetic-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology